Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
Back to team page
Katie Leyden
Director
Katie’s background in human-centered design, cultural analysis, and business positions her as both a creative and strategic thinker. She brings a cross-disciplinary understanding to ethnographic research and business analysis and has focused on various sectors including technology, e-commerce, entrepreneurship, and housing. She is driven by the desire to understand why people think the way they do and to find solutions for the everyday inconveniences. Katie graduated with a BA from the University of Notre Dame in American Studies with minors in Business Economics and Collaborative Innovation.



Bold facts
Learn more about

Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight

In your spare time (or if you had spare time), you would absolutely do this:

Your favorite city in the world is...and why?

You cannot start the day without doing this:

Your ultimate celebrity dinner party guest list would include:

Long-term personal or professional goal?

Any other facts to share?
- Bold Insight joins panel with Microsoft, IBM, and Dropbox at CRUX by User Interviews
- So you want to run a diary study: Five steps to successfully onboard participants
- Bold Insight and MedRythms co-publish article on validation study to improve walking for chronic stroke population
- 3 tips to successfully onboard in a remote environment
Read our team’s latest bold insights
Designing your POS so it’s not a POS
Regardless of whether the interface is intended to be used by a customer (novice) or an employee (expert), the key is to ensure that the POS interface is designed for the intended audience. To do this, organizations should engage users throughout the design process.
FDA’s digital health precertification program emphasizes importance of post-market surveillance
Finding efficient ways to leverage post-market surveillance data to inform product development at an institutional level will be key for SaMD manufacturers seeking FDA precertification.
5 takeaways for human factors practitioners from the HFES Health Care Symposium FDA workshops
Healthcare symposium provides clarity for interpretation of FDA guidance documents related to human factors engineering.